Shanghai Hutchison Pharmaceuticals

CompanyChina

Shanghai Hutchison Pharmaceuticals develops one asset, in phase 3 (SHPL-49 in acute ischemic stroke). Mostly small molecule; based in China.

1
Asset
Furthest stage
Phase 3
3
Trials
0
Signals

Pipeline

1
  • SHPL-49

    Investigational drug for acute ischemic stroke

    Phase 3, Small molecule, acute ischemic stroke

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials4
  • Signals1
  • Similar companies6

Intelligence